New approach tracks tumors in real time, could improve outcomes for cancer patients

NewsGuard 100/100 Score

A team of University of Alberta researchers has developed a faster way of tracking the movement of tumours in the body during radiation therapy, which could significantly improve outcomes for cancer patients.

"When a patient is getting radiation treatment, for example on the lungs, the tumour might be moving because of the patient's breathing," said Michelle Noga, a U of A radiologist who also works at MIC Medical Imaging and is the study's co-author.

"We normally have to radiate a bigger area than the actual tumour to account for that movement."

"So the idea is that if you could track their breathing and adjust the beam to match that, you wouldn't have to radiate such a big area and potentially damage healthy tissue."

The team's work builds on the Linac-MR project, a radiation beam (linear accelerator or "linac") and magnetic resonance imaging (MRI) hybrid machine developed by researchers at the Cross Cancer Institute in 2013.

As patients lie in the machine, the MRI provides constant imaging of the tumour, allowing the system to track its movement and keep the radiation focused only on that area.

However, real-time tracking requires significant processing power and the current approach is too slow for day-to-day use, said the study's lead researcher, Kumaradevan Punithakumar.

The original version of the tracking algorithm runs through the computer's central processing unit, but it can only handle eight or 12 processes at a time. That's too slow for real-time tracking," he said. "So we adapted the algorithm to use the graphics processing unit (GPU), which can handle thousands of processes at once."

Kumaradevan Punithakumar, Study Lead Researcher, University of Alberta

The U of A team--which included medical physicists Jihyun Yun and Gino Fallone, and computing scientists Nazanin Tahmasebi and Pierre Boulanger--found the GPU processing increased the speed of the process by five times.

"These are very good results," said Punithakumar, who, along with Noga, is also a member of the Women and Children's Health Research Institute.

"Improving the computational performance has been an issue for a number of imaging applications, and we've done that.

"We are also seeing improved tracking accuracy [over] previous methods. So the combination of improved performance and accuracy is a very, very good result."

Punithakumar notes that although the algorithm was applied to the Linac-MR system in this specific study, it could be used for similar medical imaging applications or other organ delineation tasks, such as cardiac ventricle segmentation using MRI.

For now, the next steps include fully integrating the algorithm into the Linac-MR system, then running more tests to ensure it consistently works as expected, Punithakumar said.

Then, the team hopes to be able to move on to clinical testing.

"In the future, this could be completely automated," Punithakumar said.

"The patient will come in, move into the machine, and the machine will be able to determine which area to target and provide that information to the oncologist."

"Once the oncologist confirms the target, then the system starts the radiation therapy, adjusting to any movement in real time automatically."

Source:
Journal reference:

Tahmasebi, N., et al. (2020) Real-Time Lung Tumor Tracking Using a CUDA Enabled Nonrigid Registration Algorithm for MRI. IEEE Journal of Translational Engineering in Health and Medicine. doi.org/10.1109/JTEHM.2020.2989124.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Prostaglandin E2: The culprit behind tumor immune evasion